Mercuri, Eugenio Maria
 Distribuzione geografica
Continente #
EU - Europa 10.607
NA - Nord America 9.711
AS - Asia 3.980
SA - Sud America 179
AF - Africa 65
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 9
Totale 24.588
Nazione #
US - Stati Uniti d'America 9.583
DE - Germania 2.965
IT - Italia 2.225
SE - Svezia 1.611
SG - Singapore 1.460
CN - Cina 1.387
IE - Irlanda 698
UA - Ucraina 654
FR - Francia 533
ID - Indonesia 433
GB - Regno Unito 392
FI - Finlandia 350
RU - Federazione Russa 340
IN - India 233
PL - Polonia 173
NL - Olanda 135
BR - Brasile 119
TR - Turchia 103
BE - Belgio 98
CA - Canada 82
AT - Austria 75
CZ - Repubblica Ceca 71
IR - Iran 68
HK - Hong Kong 59
CH - Svizzera 50
JP - Giappone 49
ES - Italia 47
CI - Costa d'Avorio 31
AU - Australia 30
LT - Lituania 27
IL - Israele 26
RO - Romania 23
AR - Argentina 20
KR - Corea 19
PA - Panama 19
PH - Filippine 19
EG - Egitto 17
MX - Messico 15
RS - Serbia 15
NO - Norvegia 14
PT - Portogallo 14
AE - Emirati Arabi Uniti 13
MK - Macedonia 13
GR - Grecia 11
MA - Marocco 11
SK - Slovacchia (Repubblica Slovacca) 11
VN - Vietnam 11
CL - Cile 10
DK - Danimarca 10
HU - Ungheria 10
PE - Perù 10
PK - Pakistan 10
CO - Colombia 9
SA - Arabia Saudita 9
TW - Taiwan 9
AZ - Azerbaigian 8
BD - Bangladesh 8
BG - Bulgaria 8
A2 - ???statistics.table.value.countryCode.A2??? 7
KZ - Kazakistan 7
NZ - Nuova Zelanda 7
KG - Kirghizistan 6
LK - Sri Lanka 6
LV - Lettonia 6
MY - Malesia 6
TH - Thailandia 6
EE - Estonia 5
HR - Croazia 5
LA - Repubblica Popolare Democratica del Laos 5
AL - Albania 4
AM - Armenia 4
BY - Bielorussia 4
EC - Ecuador 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
BO - Bolivia 3
DO - Repubblica Dominicana 3
HN - Honduras 3
LU - Lussemburgo 3
PR - Porto Rico 3
PY - Paraguay 3
BT - Bhutan 2
CY - Cipro 2
ME - Montenegro 2
MO - Macao, regione amministrativa speciale della Cina 2
OM - Oman 2
A1 - Anonimo 1
CR - Costa Rica 1
DZ - Algeria 1
GE - Georgia 1
GL - Groenlandia 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
MC - Monaco 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
NP - Nepal 1
QA - Qatar 1
Totale 24.585
Città #
Chandler 2.032
Singapore 1.000
Ashburn 892
Dublin 651
New York 445
Jakarta 432
Jacksonville 405
Rome 377
San Mateo 375
Milan 305
Nanjing 265
Wilmington 254
Munich 238
Moscow 227
Marseille 212
Boston 211
Ann Arbor 192
Dearborn 185
Helsinki 183
Nürnberg 177
Los Angeles 171
Woodbridge 159
Princeton 154
Houston 151
Warsaw 146
Fairfield 135
Lawrence 127
Seattle 122
Beijing 115
Redwood City 114
Bremen 103
Cattolica 103
Nanchang 98
Brussels 82
Chicago 78
Redmond 76
Nuremberg 72
Lancaster 67
Hebei 65
Boardman 64
Norwalk 63
Izmir 53
Shanghai 53
Detroit 51
Toronto 51
Brno 50
London 50
Mountain View 50
Shenyang 50
Hong Kong 48
Pune 47
Changsha 45
Jiaxing 45
Augusta 44
University Park 42
Jinan 40
Kish 40
Guangzhou 39
Palermo 39
Zhengzhou 38
Hangzhou 37
Leawood 37
Florence 34
Kunming 34
Cambridge 33
Falkenstein 33
Tianjin 32
Vienna 32
Abidjan 31
Council Bluffs 29
Frankfurt am Main 29
Paris 29
Washington 28
Andover 26
Busto Arsizio 26
Fremont 24
Turin 24
Bologna 23
Columbus 22
Edinburgh 22
Santa Clara 21
São Paulo 21
Pescara 20
Hefei 18
Naples 18
Ningbo 18
San Francisco 18
Stockholm 18
Ottawa 17
Zurich 17
Amsterdam 16
Sydney 16
Bari 15
Madrid 15
Prague 15
Urbino 15
Genoa 14
Messina 14
Monza 14
Inverigo 13
Totale 13.116
Nome #
Tele-riabilitazione con il Training Lettura Ritmica: Applicazione a distanza di un training ritmico-musicale per il potenziamento della lettura nella dislessia evolutiva 325
The visual function assessment: from birth to the follow up 270
Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy 259
Oral and Swallowing Abilities Tool (OrSAT) for Type 1 SMA Patients: Development of a New Module 226
Cortical visual function in preterm infants in the first year. 217
Enhanced human brain associative plasticity in Costello syndrome 196
Neurological examination of preterm infants a term equivalent age 194
Spinal muscular atrophy 194
Use of the Hammersmith Infant Neurological Examination in Infants With Cerebral Palsy: A Critical Review of the Literature 193
Neurological examination at 6 to 9 months in infants with cystic periventricular leukomalacia 169
Hammersmith Infant Neurological Examination in infants born at term: Predicting outcomes other than cerebral palsy 168
Visual function at 35 and 40 weeks' postmenstrual age in low-risk preterm infants. 165
Prognostic value of EEG performed at term age in preterm infants. 161
Sleep-potentiated epileptiform activity in early thalamic injuries: Study in a large series (60 cases) 158
Crossed cerebellar atrophy of prenatal onset 157
Performance of Upper Limb module for Duchenne muscular dystrophy 154
Application of a neonatal assessment of visual function in a population of low risk full-term newborn. 149
-Thalamic atrophy in infants with PVL and cerebral visual impairment 144
Longitudinal assessment of perceptual-motor abilities in pre-school preterm children 133
Use of the Hammersmith Infant Neurological Examination in infants with cerebral palsy: a critical review of the literature. 133
Visual development in prenatal post-haemorragic ventricular dilatation 132
Hospital admissions from the emergency department of adult patients affected by myopathies 129
Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design. 128
External hydrocephalus in discordant birth weight twins: a case report 128
Development of clinical signs in low risk term born infants with neonatal hyperexcitability 127
Cardiac Function in Types II and III Spinal Muscular Atrophy: Should We Change Standards of Care? 127
Novel de novo heterozygous loss-of-function variants in MED13L and further delineation of the MED13L haploinsufficiency syndrome 126
Antenatal post-hemorragic ventriculomegaly: a prospective follow-up study 124
Attention Deficit Hyperactivity Disorder and Cognitive Function in Duchenne Muscular Dystrophy: Phenotype-Genotype Correlation 123
SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCR. 122
Sleep disturbances in preschool age children with cerebral palsy: a questionnaire study 122
A current approach to heart failure in Duchenne muscular dystrophy 121
Muscle MRI in Becker muscular dystrophy 120
Oral and Swallowing Abilities Tool (OrSAT) in nusinersen treated patients 118
Early development in Dravet syndrome; visual function impairment precedes cognitive decline 117
Early visual assessment in preterm infants with and without brain lesions: correlation with visual and neurodevelopmental outcome at 12 months. 116
DMD myogenic cells from urine-derived stem cells recapitulate the dystrophin genotype and phenotype 116
Early assessment of visual function in preterm infants: how early is early? 114
Mutations in KANSL1 cause the 17q21.31 microdeletion syndrome phenotype 114
Neuropsychological development in children with Dravet syndrome. 113
Neuropsychological development in children with Dravet syndrome 110
Perceptual-motor abilities in pre-school preterm children 108
Sleep disturbances in preschool age children with cerebral palsy: a questionnaire study 108
Muscle MRI in Becker muscular dystrophy 106
Long Term Memory Profile of Disorders Associated with Dysregulation of the RAS-MAPK Signaling Cascade. 105
134th ENMC International Workshop: Outcome Measures and Treatment of Spinal Muscular Atrophy, 11-13 February 2005, Naarden, The Netherlands. 105
Salbutamol increases serviva motor neuron (SMN) patients: relevance for clinical trial design 104
Congenital muscular dystrophies with cognitive impairment. A population study 103
Muscle MRI: Out of the tunnel. 102
Visual processing in Noonan syndrome: dorsal and ventral stream sensitivity 102
Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study 102
Intragenic KANSL1 mutations and chromosome 17q21.31 deletions: broadening the clinical spectrum and genotype-phenotype correlations in a large cohort of patients 102
Cardiac Function in Types II and III Spinal Muscular Atrophy: Should We Change Standars of Care? 102
Revised upper limb module for spinal muscular atrophy: Development of a new module 102
Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy 101
Upper Girdle Imaging in Facioscapulohumeral Muscular Dystrophy 100
Muscle magnetic resonance imaging involvement in muscular dystrophies with rigidity of the spine 99
Neuropsychological development in children with Dravet syndrome 99
Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study 98
A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy 95
Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study. 95
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 95
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype 94
209th ENMC International Workshop: Outcome Measures and Clinical Trial Readiness in Spinal Muscular Atrophy 7-9 November 2014, Heemskerk, The Netherlands 94
Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy. 93
Expanded access program with Nusinersen in SMA type I in Italy: Strengths and pitfalls of a successful experience 93
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 93
Validation and cross-cultural adaptation of the Italian version of the Pediatric Eating Assessment Tool (I-PEDI-EAT-10) in genetic syndromes 92
24 month longitudinal data in ambulant boys with duchenne muscular dystrophy 92
FGF17, a gene involved in cerebellar development, is downregulated in a patient with Dandy-Walker malformation carrying a de novo 8p deletion 91
Contactless: a new personalised telehealth model in chronic pediatric diseases and disability during the COVID-19 era 91
Specific Learning Disorders (SLD) and behavior impairment: Comorbidity or specific profile? 91
Mutation update and genotype-phenotype correlations of novel and previously described mutations in TPM2 and TPM3 causing congenital myopathies 90
Assessing Joint Hypermobility in Preschool-Aged Children 90
Experience of a 2-year spinal muscular atrophy NBS pilot study in Italy: towards specific guidelines and standard operating procedures for the molecular diagnosis 89
Application of a neonatal assessment of visual function in a population of low risk full-term newborn 89
Are high cumulative doses of erythropoietin neuroprotective in preterm infants? A two year follow-up report 89
Predominant distal muscle involvement in spinal muscular atrophy 89
Visual processing in Noonan syndrome: dorsal and ventral stream sensitivity 88
Visual and visuoperceptual function in children with Panayiotopoulos syndrome 87
MRI: Out of the tunnel. 87
Neurological assessment of newborns with spinal muscular atrophy identified through neonatal screening 87
Disorders of early language development in Dravet syndrome 85
Cognitive-behavioral profiles in teenagers with Dravet syndrome 85
The empowerment of translational research: lessons from laminopathies 85
Mutations in KANSL1 cause the 17q21.31 microdeletion syndrome phenotype 84
Behavioral profile in RASopathies 84
Predictive models in SMA II natural history trajectories using machine learning: A proof of concept study 84
Calf muscle involvement in Becker muscular dystrophy: When size does not matter 83
Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data. 82
Early Childhood Attention Battery: Italian adaptation and new expanded normative data. 82
Developmental milestones in type I spinal muscular atrophy 81
Early Childhood Attention Battery: Italian adaptation and new expanded normative data. 81
Early visual and neuro-development in preterm infants with and without retinopathy 81
Respiratory Needs in Patients with Type 1 Spinal Muscular Atrophy Treated with Nusinersen 80
Timed Rise from Floor as a Predictor of Disease Progression in Duchenne Muscular Dystrophy: An Observational Study 80
The Spinal Muscular Atrophy Health Index: Italian validation of a disease-specific outcome measure 79
Auditory processing in infancy: do early abnormalities predict disorders of language and cognitive development? 78
Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: results of a phase IIb double-blind study of salbutamol 78
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial 78
Totale 11.724
Categoria #
all - tutte 133.412
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 133.412


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020689 0 0 0 0 0 0 0 0 107 142 289 151
2020/20211.578 73 163 31 138 200 137 211 43 209 90 262 21
2021/20222.605 221 137 75 185 140 104 52 417 144 178 468 484
2022/20236.206 713 764 452 923 398 774 377 538 754 88 254 171
2023/20244.498 185 913 143 292 171 707 473 202 108 228 447 629
2024/20254.077 211 238 667 445 774 439 425 418 460 0 0 0
Totale 25.061